Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 12, 2024, before the open
10-Q filed Nov 12, 2024, 43 days after period end · 0000950170-24-124664
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$3.49M | -$3.60M | -$3.99M | $8.09M |
| EPS Diluted | -$2.32 | -$7.38 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$4.10 |
| $0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
